Company intelligence / Profile preview

GAVIS Pharmaceuticals

Somerset, New Jersey, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

GAVIS developed, manufactured, and distributed a wide range of specialty and generic pharmaceutical products, including many difficult-to-make, high-value, niche generics in solid oral, chewable, and liquid dosage forms. It had 62 ANDA filings pending FDA approval and a pipeline of 65+ products at the time of acquisition, with several first-to-file (FTF) and Para IV Paragraph IV generic applications. The company’s focus was on specialty, controlled substances, and dermatology areas, often targeting products with few or no generics available.[4][6][9][12]

Modalities: Small moleculeModified-release tabletCapsuleOrally disintegrating tabletTopical solutionChewable tablet
Industry: Biotech

Beyond the preview

Go deeper on GAVIS Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GAVIS Pharmaceuticals.

Explore the full profile